# Hypertensive Emergency â€“ Clinical Call Protocol

**Guidelines Referenced:**  
AHA/ACC 2017 High Blood Pressure Clinical Practice Guideline, ESC/ESH 2018 Guidelines for the Management of Arterial Hypertension, AHA 2019 Scientific Statement on Treatment of Hypertensive Crises

**Official Sources:**  
https://www.ahajournals.org/doi/10.1161/HYP.0000000000000065  
https://academic.oup.com/eurheartj/article/39/33/3021/5079119  
https://www.ahajournals.org/doi/10.1161/HYP.0000000000000099

## CARD INTERFACE LAYOUT

### Card 0 â€“ Dynamic Action Card (Node Dependent)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ HYPERTENSIVE EMERGENCY                                      â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                            â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                        â”‚
â”‚ â”‚     IMMEDIATE ACTIONS           â”‚                        â”‚
â”‚ â”‚ â˜‘ Confirm BP (both arms)        â”‚ [L: 236/138, R: 232/140]â”‚
â”‚ â”‚ â˜‘ IV access x2                 â”‚ [18G bilateral]        â”‚
â”‚ â”‚ â˜‘ Continuous BP monitoring      â”‚ [Q5min initially]      â”‚
â”‚ â”‚ â˜‘ STAT: BMP, troponin, UA      â”‚ [Labs pending]         â”‚
â”‚ â”‚ â˜‘ ECG - evaluate LVH/ischemia  â”‚ [LVH present]          â”‚
â”‚ â”‚ â˜‘ Fundoscopic exam             â”‚ [Papilledema noted]    â”‚
â”‚ â”‚ â˜ CT head if neuro symptoms    â”‚ [Order STAT]           â”‚
â”‚ â”‚ â˜ CXR for pulmonary edema      â”‚ [Assess CHF]           â”‚
â”‚ â”‚                                â”‚                        â”‚
â”‚ â”‚ Target MAP: 137-154 (â†“10-20%)  â”‚                        â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                        â”‚
â”‚                                                           â”‚
â”‚ VITALS: BP 236/138 (MAP 171), HR 96, RR 20, SpO2 97%, T 37.2Â°Câ”‚
â”‚                                                           â”‚
â”‚ END-ORGAN DAMAGE ASSESSMENT:                               â”‚
â”‚ â˜‘ Neurologic: Confusion, severe headache                  â”‚
â”‚ â˜‘ Cardiac: Chest pain, troponin pending                   â”‚
â”‚ â˜‘ Renal: Cr 2.1 (baseline 1.0)                           â”‚
â”‚ â˜‘ Retinal: Papilledema present                            â”‚
â”‚                                                           â”‚
â”‚ ğŸš¨ TRUE EMERGENCY - Requires ICU                          â”‚
â”‚ Goal: â†“ MAP by 10-20% in first hour                       â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Example - IV Antihypertensive Management Node:**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ IV ANTIHYPERTENSIVE MANAGEMENT                              â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ CURRENT STATUS: BP 236/138 â†’ 218/128 (after 30 min)        â”‚
â”‚ MAP: 171 â†’ 158 (â†“ 7.6%) | Symptoms: Persistent headache     â”‚
â”‚                                                           â”‚
â”‚ â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                        â”‚
â”‚ â”‚     NICARDIPINE INFUSION        â”‚                        â”‚
â”‚ â”‚                                â”‚                        â”‚
â”‚ â”‚ Starting dose: 5 mg/hr IV       â”‚ [â–²â–¼ Titrate]          â”‚
â”‚ â”‚ Current rate: 7.5 mg/hr         â”‚ [Increase q5-15min]   â”‚
â”‚ â”‚ Maximum rate: 15 mg/hr          â”‚ [Safety limit]        â”‚
â”‚ â”‚                                â”‚                        â”‚
â”‚ â”‚ Time    BP        MAP   Rate    â”‚                        â”‚
â”‚ â”‚ 10:00   236/138   171   Start 5 â”‚                        â”‚
â”‚ â”‚ 10:15   228/132   164   â†‘ to 7.5â”‚                        â”‚
â”‚ â”‚ 10:30   218/128   158   â†‘ to 10 â”‚                        â”‚
â”‚ â”‚ 10:45   206/118   147   Hold    â”‚                        â”‚
â”‚ â”‚                                â”‚                        â”‚
â”‚ â”‚ Target MAP: 137-154 (â†“20% from 171)â”‚                     â”‚
â”‚ â”‚ Status: ON TARGET âœ“             â”‚                        â”‚
â”‚ â”‚                                â”‚                        â”‚
â”‚ â”‚ [TITRATE] [SWITCH AGENT] [ADD 2ND]â”‚                      â”‚
â”‚ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                        â”‚
â”‚                                                           â”‚
â”‚ TRANSITION PLANNING:                                       â”‚
â”‚ â€¢ Once stable x 24h on IV                                 â”‚
â”‚ â€¢ Start long-acting PO agents                             â”‚
â”‚ â€¢ Overlap x 2-4 hours before stopping IV                  â”‚
â”‚                                                           â”‚
â”‚ âš ï¸ Avoid excessive BP reduction                            â”‚
â”‚ Risk of stroke if MAP â†“ >25% acutely                      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Card 1 â€“ Static Assessment/Classification

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ HYPERTENSIVE CRISIS CLASSIFICATION                          â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ EMERGENCY vs URGENCY:                                      â”‚
â”‚ â€¢ Emergency: BP >180/120 + acute end-organ damage          â”‚
â”‚   Requires IV therapy, ICU admission, â†“10-20% in 1st hour  â”‚
â”‚ â€¢ Urgency: BP >180/120 + NO end-organ damage              â”‚
â”‚   PO therapy acceptable, outpatient possible, â†“over 24-48h  â”‚
â”‚                                                           â”‚
â”‚ END-ORGAN MANIFESTATIONS:                                  â”‚
â”‚ â€¢ Neurologic: Encephalopathy, ICH, ischemic stroke, PRES   â”‚
â”‚ â€¢ Cardiovascular: ACS, acute HF, aortic dissection        â”‚
â”‚ â€¢ Renal: Acute kidney injury, hematuria, proteinuria      â”‚
â”‚ â€¢ Ophthalmologic: Papilledema, flame hemorrhages          â”‚
â”‚ â€¢ Obstetric: Preeclampsia/eclampsia, HELLP syndrome       â”‚
â”‚                                                           â”‚
â”‚ PRECIPITATING FACTORS:                                     â”‚
â”‚ â€¢ Medication non-adherence (#1 cause)                     â”‚
â”‚ â€¢ Rebound (clonidine), drug interactions                  â”‚
â”‚ â€¢ Cocaine/amphetamines, OTC sympathomimetics              â”‚
â”‚ â€¢ Renovascular disease, pheochromocytoma                  â”‚
â”‚                                                           â”‚
â”‚ CRITICAL HISTORY:                                          â”‚
â”‚ Prior BP control, current medications, adherence, substance â”‚
â”‚ use, pregnancy status, prior strokes/MI, CKD, home readingsâ”‚
â”‚                                                           â”‚
â”‚ RED FLAGS: Severe headache, vision changes, chest pain,    â”‚
â”‚ altered mental status, seizures, dyspnea, oliguria        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Card 2 â€“ Static Physical Exam/Medications

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ PHYSICAL EXAM & MEDICATIONS                                 â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ FOCUSED EXAMINATION:                                       â”‚
â”‚ â€¢ Vitals: BP both arms, orthostatic if safe, HR/rhythm     â”‚
â”‚ â€¢ Neurologic: Mental status, focal deficits, fundoscopy    â”‚
â”‚ â€¢ Cardiovascular: JVD, S3/S4, murmurs, peripheral pulses   â”‚
â”‚ â€¢ Pulmonary: Rales (pulmonary edema), work of breathing    â”‚
â”‚ â€¢ Abdominal: Bruits (RAS), pulsatile mass (AAA)           â”‚
â”‚                                                           â”‚
â”‚ ğŸ’Š IV ANTIHYPERTENSIVES:                                   â”‚
â”‚ â€¢ Nicardipine (1st line): 5 mg/hr, â†‘2.5 mg/hr q5-15min   â”‚
â”‚   Max 15 mg/hr, onset 5-10min, no rebound                â”‚
â”‚ â€¢ Labetalol: 20mg IV q10min, double each dose, max 80mg   â”‚
â”‚   Infusion 0.5-2 mg/min, avoid in cocaine/asthma         â”‚
â”‚ â€¢ Esmolol: Load 500 mcg/kg/min x1, then 50-200 mcg/kg/minâ”‚
â”‚   Ultra-short acting, good for aortic dissection         â”‚
â”‚                                                           â”‚
â”‚ ğŸ’Š SPECIFIC SCENARIOS:                                     â”‚
â”‚ â€¢ Acute stroke: Permissive HTN unless tPA (<185/110)      â”‚
â”‚ â€¢ Aortic dissection: Beta-blocker FIRST, then vasodilator â”‚
â”‚ â€¢ ACS/Pulmonary edema: Nitroglycerin + loop diuretic     â”‚
â”‚ â€¢ Preeclampsia: Labetalol or hydralazine + MgSO4         â”‚
â”‚ â€¢ Cocaine: Benzodiazepines first, avoid pure beta-blockersâ”‚
â”‚                                                           â”‚
â”‚ ğŸ’Š ORAL TRANSITION (when stable x24h):                    â”‚
â”‚ Start PO 2-4h before stopping IV: Long-acting CCB         â”‚
â”‚ (amlodipine), ACE-I/ARB, thiazide diuretic               â”‚
â”‚                                                           â”‚
â”‚ âš ï¸ AVOID: Immediate-release nifedipine, sublingual meds,   â”‚
â”‚ >25% reduction in 1st hour, abrupt discontinuation        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## FLOWCHART (Bottom Panel â€“ Mermaid Algorithm)

```mermaid
graph TD
    A[BP >180/120 & Symptomatic]
    B{End-Organ Damage?}
    C[HYPERTENSIVE EMERGENCY]
    D[Hypertensive Urgency]
    E[ICU Admission & Arterial Line]
    F[PO Medications & Close Follow-up]
    G{Identify Syndrome}
    H[Permissive HTN Unless tPA]
    I[Nitro/Labetalol & Treat ACS]
    J[BB First Then Vasodilator]
    K[Nicardipine & Avoid ACE-I Acutely]
    L[Nicardipine Goal â†“10-20%/hr]
    M[Esmolol plus Nicardipine Goal SBP <120]
    N{At Goal in 1 hour?}
    O[Continue Current & Monitor q15min]
    P[Increase Rate or Add 2nd Agent]
    Q{Stable x 24h?}
    R[Transition to PO & Overlap 2-4h]
    S[Continue IV & Adjust PRN]
    T[Discharge Planning & Close F/U]
    U[Reinstitute Meds & Address Adherence]
    V[F/U in 1 week & Home BP log]

    A --> B
    B -- Yes --> C
    B -- No --> D
    C --> E
    D --> F
    E --> G
    G -- Neurologic --> H
    G -- Cardiac --> I
    G -- Aortic --> J
    G -- Renal --> K
    H --> L
    I --> L
    J --> M
    K --> L
    L --> N
    N -- Yes --> O
    N -- No --> P
    O --> Q
    P --> Q
    Q -- Yes --> R
    Q -- No --> S
    R --> T
    F --> U
    U --> V
```

## INTERACTIVE ELEMENTS

### BP Reduction Calculator
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚      BP REDUCTION TARGETS               â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ Initial BP: 236/138 (MAP 171)          â”‚
â”‚                                         â”‚
â”‚ HOUR 1 GOALS:                           â”‚
â”‚ 10-20% MAP reduction                    â”‚
â”‚ Target MAP: 137-154                     â”‚
â”‚ Target BP: ~190-210/110-125            â”‚
â”‚                                         â”‚
â”‚ CURRENT STATUS (45 min):                â”‚
â”‚ BP: 206/118 (MAP 147)                   â”‚
â”‚ MAP Reduction: 14% âœ“ ON TARGET          â”‚
â”‚                                         â”‚
â”‚ Progress Timeline:                      â”‚
â”‚ 0 min:   236/138 (MAP 171)            â”‚
â”‚ 15 min:  228/132 (MAP 164) â†“4%        â”‚
â”‚ 30 min:  218/128 (MAP 158) â†“8%        â”‚
â”‚ 45 min:  206/118 (MAP 147) â†“14%       â”‚
â”‚                                         â”‚
â”‚ 24-48 HOUR GOAL: BP <160/100           â”‚
â”‚                                         â”‚
â”‚ [ADJUST TARGETS] [GRAPH TREND]          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### IV Antihypertensive Selection Tool
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚    ANTIHYPERTENSIVE SELECTION           â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ Clinical Scenario Selected:              â”‚
â”‚ â˜‘ Acute kidney injury                  â”‚
â”‚                                         â”‚
â”‚ RECOMMENDED AGENTS:                     â”‚
â”‚                                         â”‚
â”‚ 1st Line: NICARDIPINE                   â”‚
â”‚ â€¢ No contraindications for AKI          â”‚
â”‚ â€¢ Predictable, titratable response      â”‚
â”‚ â€¢ Start 5 mg/hr, â†‘2.5 mg/hr q5-15min   â”‚
â”‚ â€¢ Max 15 mg/hr                          â”‚
â”‚                                         â”‚
â”‚ Alternatives:                           â”‚
â”‚ â€¢ Labetalol (if no asthma/COPD)        â”‚
â”‚ â€¢ Hydralazine (less predictable)       â”‚
â”‚                                         â”‚
â”‚ AVOID in AKI:                           â”‚
â”‚ â€¢ ACE inhibitors (worsen acute AKI)     â”‚
â”‚ â€¢ ARBs (worsen acute AKI)              â”‚
â”‚                                         â”‚
â”‚ [DOSING CALCULATOR] [SWITCH SCENARIO]    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### IV to PO Transition Planner
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚      IV TO PO TRANSITION PLANNER        â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ Current IV: Nicardipine 10 mg/hr x 36h  â”‚
â”‚ Current BP: 148/92 (stable)            â”‚
â”‚                                         â”‚
â”‚ RECOMMENDED PO REGIMEN:                 â”‚
â”‚ Start 2-4 hours before stopping IV:     â”‚
â”‚                                         â”‚
â”‚ â˜‘ Amlodipine 5mg PO daily              â”‚
â”‚   (Long-acting CCB equivalent)          â”‚
â”‚                                         â”‚
â”‚ â˜‘ Lisinopril 10mg PO daily             â”‚
â”‚   (Hold if Cr rising)                   â”‚
â”‚                                         â”‚
â”‚ â˜‘ Chlorthalidone 12.5mg PO daily       â”‚
â”‚   (Preferred over HCTZ)                 â”‚
â”‚                                         â”‚
â”‚ OVERLAP SCHEDULE:                       â”‚
â”‚ 08:00 - Give PO medications             â”‚
â”‚ 10:00 - Reduce nicardipine to 7.5 mg/hrâ”‚
â”‚ 11:00 - Reduce to 5 mg/hr              â”‚
â”‚ 12:00 - Stop nicardipine                â”‚
â”‚ Monitor BP q30min x 2h after stopping   â”‚
â”‚                                         â”‚
â”‚ [CALCULATE DOSES] [PRINT ORDERS]        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

## VIRTUA VOORHEES HYPERTENSIVE EMERGENCY ADDENDA

- **ICU Capabilities:** Arterial line monitoring, continuous nicardipine infusions, q15-minute BP monitoring protocols
- **Cardiology Consultation:** 24/7 availability via Transfer Center 856-886-5111 for complex cases or aortic dissection
- **Neurology Support:** Immediate access for hypertensive encephalopathy, stroke evaluation, and PRES syndrome
- **Quality Metrics:** Time to appropriate IV antihypertensive, goal BP achievement within 1 hour, medication reconciliation at discharge

## REFERENCE (GUIDELINE & SOURCE)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.  
https://www.ahajournals.org/doi/10.1161/HYP.0000000000000065

**Additional References:**  
2018 ESC/ESH Guidelines for the Management of Arterial Hypertension  
https://academic.oup.com/eurheartj/article/39/33/3021/5079119

2019 AHA Scientific Statement on Treatment of Hypertensive Crises  
https://www.ahajournals.org/doi/10.1161/HYP.0000000000000099

**All steps follow current evidence-based guidelines for hypertensive emergency management with integrated BP reduction targets, scenario-specific antihypertensive selection, and optimized transition protocols to prevent rebound hypertension.**
